CARE attracts Swiss NHL player Kevin Fiala
CARE attracts Swiss NHL player Kevin Fiala unknown
In addition to his investment, Swiss NHL player Kevin Fiala will act as U.S. brand ambassador for CARE, the evidence-based preventive medicine to support its planned expansion to the U.S. market.
CARE offers services in the field of evidence-based preventive medicine. It carries out detailed check-ups and enables customers to track the data collected via the CARE App in an intuitive way and use it to optimize their own health. Top athletes know the importance of prevention in maintaining peak performance. Thanks to CARE, evidence-based preventive medicine is no longer just available to professional athletes, but to anyone interested in improving their health.
This idea has also won over professional athletes such as professional soccer player Yann Sommer who invested in CARE as part of a seed financing round. Swiss NHL forward Kevin Fiala, the Los Angeles Kings player, recently joined the start-up as an investor and as a brand ambassador, securing the support of a prominent voice in U.S. professional sports landscape.
At the beginning of 2023, CARE opened its first store in Zurich and after only six months was able to generate an annual recurring revenue (ARR) of one million Dollars. After a successful start in Switzerland, the company is now preparing to expand to the U.S. The first U.S. store is scheduled to open in Miami in January 2024. To support the implementation of its ambitious plans, CARE recently announced the appointment of former Technogym U.S. managing director Kay Oswald as CEO.
"I'm proud to be part of the CARE success story as an investor. For me personally, CARE is a real game changer because it allows me to take control of my health and be proactive. It tells me exactly where I need to make improvements. And that is the key to a healthier life", said Kevin.
High growth ambitions
By the end of 2024, CARE plans to add additional locations in the U.S., and the number of members is projected to rise to 5,000. CARE offers innovative, personalized, data-driven health assessments and blood analysis to guide and empower members with actionable plans and subscription-based services. By leveraging scientific advancements, proprietary technology and on-going in-person coaching, CARE unlocks critical insights for members to help improve the quality of their daily lives and delay the impact of aging. With the proprietary CARE App, members are empowered in the planning and tracking of their CARE Score and more than 50 biomarkers to achieve their goals. In pursuit of its ambitious growth targets, the company plans to increase the number of employees to 100 by the end of 2024.
(Press release/ran)